Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Infrequent p53 gene mutations in medulloblastomas.

R L Saylors¹, D Sidransky, H S Friedman

¹Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Cancer Research

|September 1, 1991

Summary

Frequent chromosome 17 short arm losses in medulloblastoma may involve the p53 tumor suppressor gene. However, p53 mutations were rare in tumors and xenografts, suggesting alternative genetic mechanisms in medulloblastoma development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erratum to "Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation" [Diagn. Interv. Imaging. 101 (2020) 35-44].

Diagnostic and interventional imaging·2020

Same author

Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.

Diagnostic and interventional imaging·2020

Same author

Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis.

Diagnostic and interventional imaging·2019

Same author

Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation.

Diagnostic and interventional imaging·2019

Same author

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Same author

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Area of Science:

Oncology
Genetics
Molecular Biology

Background:

Medulloblastomas frequently exhibit chromosomal aberrations, specifically deletions on the short arm of chromosome 17.
These genetic alterations suggest a potential role for tumor suppressor genes, such as p53, in medulloblastoma pathogenesis.

Purpose of the Study:

To investigate the mutation status of the p53 tumor suppressor gene in medulloblastoma.
To determine if p53 gene mutations correlate with the observed chromosome 17 short arm deletions in medulloblastoma.

Main Methods:

Polymerase chain reaction (PCR) was used to amplify critical exons (5-8) of the p53 gene.
DNA sequencing was performed on amplified p53 gene segments from medulloblastoma tumors, xenografts, and cell lines.
Analysis focused on regions known to harbor common mutations in human cancers.

Related Experiment Videos

Main Results:

P53 gene mutations were detected in only one of three medulloblastoma cell lines.
No p53 mutations were identified in the twelve primary medulloblastoma tumors or eight xenografts studied.
This indicates a low frequency of canonical p53 mutations in these medulloblastoma samples.

Conclusions:

The findings suggest that p53 mutations are not a primary driver in most medulloblastomas.
Alternative mechanisms, possibly involving a different tumor suppressor gene on chromosome 17 short arm, may contribute to medulloblastoma development.
Further research is needed to elucidate the genetic landscape of medulloblastoma beyond p53.